In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease

This in silico study has conclusively predicted the superiority of the natural compound quercetin over the conventional drugs as AchE inhibitor and it sets the need for further in-vitro study of this compound in future.